Platelet-derived serotonin links vascular disease and tissue fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Vascular damage and platelet activation are associated with tissue remodeling in diseases such as systemic sclerosis, but the molecular mechanisms underlying this association have not been identified. In this study, we show that serotonin (5-hydroxytryptamine [5-HT]) stored in platelets strongly induces extracellular matrix synthesis in interstitial fibroblasts via activation of 5-HT2B receptors (5-HT2B) in a transforming growth factor β (TGF-β)–dependent manner. Dermal fibrosis was reduced in 5-HT2B−/− mice using both inducible and genetic models of fibrosis. Pharmacologic inactivation of 5-HT2B also effectively prevented the onset of experimental fibrosis and ameliorated established fibrosis. Moreover, inhibition of platelet activation prevented fibrosis in different models of skin fibrosis. Consistently, mice deficient for TPH1, the rate-limiting enzyme for 5-HT production outside the central nervous system, showed reduced experimental skin fibrosis. These findings suggest that 5-HT/5-HT2B signaling links vascular damage and platelet activation to tissue remodeling and identify 5-HT2B as a novel therapeutic target to treat fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. 5-HT2B is overexpressed in patients with SSc. (A) 5-HT2B was detectable by immunohistochemistry in fibroblasts, keratinocytes, and microvessels of SSc patients and controls. Two representative tissue sections and an isotype control are shown. (B) 5-HT2B expression in SM22-α–negative and α-SMA–positive myofibroblasts. A representative skin section of an SSc patient is shown. SM22-α as specific marker for vascular smooth muscle cells was stained with DAB, the myofibroblast marker α-SMA with Alexa Flour 594 (red), and 5-HT2B with Alexa Flour 488 (green; n = 8 each). The stainings were performed in three independent series. Bars: (A and B [top]) 50 µm; (B, bottom) 10 µm.](https://figures.cochat.ai/paper-figures/2d4bce77e10e467e91ca2a569232e136/platelet-derived-serotonin-links-vascular-disease-and-tissue-fibrosis-figure-3.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, mice that lack this receptor (5H-T2b-/-) are protected against bleomycin-induced skin fibrosis, just as mice in which the 5H-T2b, receptor is pharmacologically inhibited (149).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
In the citing paper
“This effect runs via the 5H-T2b receptor; inhibition of this receptor with terguride decreases collagen and fibronectin production by fibroblasts.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
In the citing paper
“More recently, it was demonstrated that serotonin directly increases extracellular matrix production in primary skin fibroblasts (149).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840 · cited 1×
“To detect also highly cross-linked collagen, the collagen content in skin samples was analyzed by determination of the hydroxyproline content ( Woessner, 1961 ).”
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,312 · cited 1×
“Nuclear and cytoplasmic extracts were prepared as previously described ( Andrews and Faller, 1991 ; Khelifi et al., 2005 ).”
Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform
Walther, D. J., Peter, J.-U., Bashammakh, S., Hörtnagl, H., Voits, M., Fink, H., & Bader, M. (2003) · Science · doi:10.1126/science.1078197 · Cited by 1,570 · cited 4×
“TPH1 # / # mice and 5-HT2B # / # mice have been described previously ( Nebigil et al., 2000 ; Walther et al., 2003b ).”
InfluentialChanges in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472 · cited 1×
“…fibrotic diseases such as systemic sclerosis (SSc) and organ-specific fibrosis such as kidney fibrosis, idiopathic pulmonary fibrosis, and liver cirrhosis share common pathophysiological mechanisms (Bataller and Brenner, 2005; Varga and Abraham, 2007; Strieter and Mehrad, 2009).”
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722
Research works printed but not linked: 1
- von Werner, 1989, Therapy with terguride, Nichidoku-Iho., 33, 189
Cited by
Items 101–200 of 302
Tomčík, M., Palumbo‐Zerr, K., Zerr, P., Šumová, B., Avouac, J., Dees, C., Distler, A., Bečvář, R., Distler, O., Schett, G. A., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206234 · Cited by 45
Self-citationCurrent and Potential New Targets in Systemic Sclerosis Therapy: a New Hope
Hinchcliff, M., & O’Reilly, S. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00918-3 · Cited by 44
Rahmanian‐Devin, P., Rakhshandeh, H., Rahimi, V. B., Sanei‐Far, Z., Hasanpour, M., Memarzia, A., Iranshahi, M., & Askari, V. R. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5945101 · Cited by 44
Stegemann, A., Sindrilaru, A., Eckes, B., del Rey, A., Heinick, A., Schulte, J. S., Müller, F. U., Grando, S. A., Fiebich, B. L., Scharffetter‐Kochanek, K., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37809 · Cited by 44
Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis
Zhang, Y., Pötter, S., Chen, C., Liang, R., Gelse, K., Ludolph, I., Horch, R. E., Distler, O., Schett, G. A., Distler, J. H. W., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212265 · Cited by 43
Self-citationPlatelets induce endothelial–mesenchymal transition and subsequent fibrogenesis in endometriosis
Yan, D., Liu, X., Xu, H., & Guo, S. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.03.020 · Cited by 42
Current frontiers in systemic sclerosis pathogenesis
Ciechomska, M., van Laar, J. M., & O’Reilly, S. (2015) · Experimental Dermatology · doi:10.1111/exd.12673 · Cited by 41
Serotonin contribution to cardiac valve degeneration: new insights for novel therapies?
Ayme‐Dietrich, E., Lawson, R., Silva, S. D., Mazzucotelli, J. P., & Monassier, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.009 · Cited by 41
Beyer, C., Huang, J., Beer, J., Zhang, Y., Palumbo‐Zerr, K., Zerr, P., Distler, A., Dees, C., Maier, C., Munoz, L. E., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204401 · Cited by 40
Self-citationInhibition of angiogenesis by platelets in systemic sclerosis patients
Hirigoyen, D., Burgos, P. I., Mezzano, V., Durán, J., Barrientos, M. J., Sáez, C. G., Panes, O., Mezzano, D., & Iruretagoyena, M. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0848-2 · Cited by 40
Palumbo‐Zerr, K., Horn, A., Distler, A., Zerr, P., Dees, C., Beyer, C., Selvi, E., Cravatt, B. F., Distler, O., Schett, G. A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201823 · Cited by 40
Self-citationYang, T., Wang, H., Li, Y., Zeng, Z., Shen, Y., Wan, C., Wu, Y., Dong, J., Chen, L., & Wen, F. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106036 · Cited by 39
Han, R. I., Clark, C., Black, A., French, A. T., Culshaw, G., Kempson, S., & CORCORAN, B. M. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2013.01.027 · Cited by 39
“If activated platelets were contributing to the pathogenesis it would likely be through serotonin (5-hydroxytryptamine [5-HT]) activation of the 5-HT2B receptor-dependent TGF-b signalling pathway, which would be expected to result in fibrosis (Dees et al., 2011).”
BackgroundDistler, A., Lang, V. R., Vecchio, T. D., Huang, J., Zhang, Y., Beyer, C., Lin, N., Palumbo‐Zerr, K., Distler, O., Schett, G. A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204221 · Cited by 39
Self-citationActivating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis
Mallano, T., Palumbo‐Zerr, K., Zerr, P., Ramming, A., Zeller, B., Beyer, C., Dees, C., Huang, J., Hai, T., Distler, O., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206214 · Cited by 38
Self-citationJaafari, A., Rahimi, V. B., Vahdati-Mashhadian, N., Yahyazadeh, R., Ebrahimzadeh‐Bideskan, A., Hasanpour, M., Iranshahi, M., Ehtiati, S., Rajabi, H., Mahdinezhad, M. R., et al. (2021) · Mediators of Inflammation · doi:10.1155/2021/8437753 · Cited by 38
“In this study, para ffi n-embedded histological sections were stained by Masson ’ s trichrome staining to assess the extent and distribution of fi brosis in rats ’ peritoneal tissue as described by the manufacturer (Sigma-Aldrich) [34, 35].”
Pomalidomide is effective for prevention and treatment of experimental skin fibrosis
Weingärtner, S., Zerr, P., Tomčík, M., Palumbo‐Zerr, K., Distler, A., Dees, C., Beyer, C., Shankar, S. L., Cedzik, D., Schafer, P. H., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201784 · Cited by 38
“Analysis of murine skin Dermal thickness, hydroxyproline content and α-smooth muscle actin were analysed as described.(9) 11 12”
Self-citationLu, W., Teoh, A. K. Y., Waters, M., Haug, G., Shakeel, I., Hassan, M. I., Shahzad, A. M., Larsson‐Callerfelt, A., Piccari, L., & Sohal, S. S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108757 · Cited by 37
Chaturvedi, S., Misra, D. P., Prasad, N., Rastogi, K., Singh, H., Rai, M. K., & Agarwal, V. (2018) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13386 · Cited by 37
“In the present study, 5‐HT induced mRNA expression of TGF‐β1 in a dose‐dependent manner, which is consistent with a previous report.(8) The data from our study demonstrated that 5‐HT‐dependent TGF‐β1 signaling activated both canonical and non‐canonical signaling pathways.”
BackgroundResultInfluentialNtelis, K., Bogdanos, D. P., Dimitroulas, T., Sakkas, L. I., & Daoussis, D. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0815-z · Cited by 37
Hong, Y., Lee, Y., Cheng, T., Lai, C., Hsu, C., Kuo, C., Hsu, Y.-Y., Li, J.-T., Chang, B.-I., Ma, C.-Y., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.03.1149 · Cited by 37
Löfdahl, A., Rydell‐Törmänen, K., Müller, C., Holst, C. M., Thiman, L., Ekström, G. M., Wenglén, C., Larsson‐Callerfelt, A., & Westergren‐Thorsson, G. (2016) · Physiological Reports · doi:10.14814/phy2.12873 · Cited by 36
“Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society. event that is associated with increased endothelial permeability, myofibroblasts count, and ECM deposition (Dees et al. 2011; Andersson-Sjoland et al. 2016).”
BackgroundInfluentialThe contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis
Pauling, J. D., O’Donnell, V. B., & McHugh, N. J. (2012) · Platelets · doi:10.3109/09537104.2012.719090 · Cited by 36
“[92], meanwhile, would support further assessment of P2Y12 receptor inhibition on the dermal and visceral fibrosis in SSc.”
BackgroundInfluentialZhang, J., Cui, R., Feng, Y., Gao, W., Bi, J., Li, Z., & Liu, C. (2018) · Mediators of Inflammation · doi:10.1155/2018/7967868 · Cited by 35
Papadimitriou, T. I., van Caam, A., van der Kraan, P. M., & Thurlings, R. M. (2022) · Biomedicines · doi:10.3390/biomedicines10020316 · Cited by 34
“Tryptase and histamine release triggers fibroblast proliferation [38,39].”
BackgroundKondo, M., Suzuki, T., Kawano, Y., Kojima, S., Miyashiro, M., Matsumoto, A., Kania, G., Błyszczuk, P., Ross, R. L., Mulipa, P., et al. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02899-3 · Cited by 34
Self-citationHoirisch-Clapauch, S., Nardi, A. E., Gris, J., & Brenner, B. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.02.028 · Cited by 33
“Serotonin was also found to stimulate extracellular matrix synthesis in interstitial fibroblasts and promote tissue fibrosis [28].”
BackgroundOptimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors
Goldberg, D. R., Lombaert, S. D., Aiello, R. J., Bourassa, P., Barucci, N., Zhang, Q., Paralkar, V. M., Stein, A. J., Holt, M. C., Valentine, J., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.12.053 · Cited by 33
Platelets in Skin Autoimmune Diseases
Liu, X., Gorzelanny, C., & Schneider, S. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01453 · Cited by 33
“In SSc mice models, clopidogrel has been shown to decrease fibrosis (154).”
BackgroundInfluentialTargeting the serotonin pathway for the treatment of pulmonary arterial hypertension
Thomas, M. J., Ciuclan, L. I., Hussey, M. J., & Press, N. J. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.02.002 · Cited by 31
Use of biologics and other novel therapies for the treatment of systemic sclerosis
Bruni, C., Praino, E., Allanore, Y., Distler, O., Gabrielli, A., Iannone, F., & Matucci‐Cerinic, M. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1263153 · Cited by 31
Self-citationSerum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Meier, C. F., Freiburghaus, K., Bovet, C., Gote-Schniering, J., Allanore, Y., Distler, O., Nakas, C. T., & Maurer, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-78951-6 · Cited by 30
Self-citationStructure, Function, and Pharmaceutical Ligands of 5-Hydroxytryptamine 2B Receptor
Wang, Q., Zhou, Y., Huang, J., & Huang, N. (2021) · Pharmaceuticals · doi:10.3390/ph14020076 · Cited by 30
“In addition, mice lacking the 5-HT2B gene could be protected from BLM-induced fibrosis [39].”
BackgroundEmerging therapies for the treatment of systemic sclerosis
Distler, J. H. W., Kuwana, M., Assassi, S., & Denton, C. P. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01294-x · Cited by 29
Self-citationLöfdahl, A., Wenglén, C., Rydell‐Törmänen, K., Westergren‐Thorsson, G., & Larsson‐Callerfelt, A. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.01.006 · Cited by 29
Distler, A., Ziemer, C., Beyer, C., Lin, N., Chen, C., Palumbo‐Zerr, K., Dees, C., Weidemann, A., Distler, O., Schett, G. A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203995 · Cited by 29
Self-citationMicrovessel Mechanobiology in Pulmonary Arterial Hypertension: Cause and Effect
Bloodworth, N. C., West, J. D., & Merryman, W. D. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.04652 · Cited by 29
“In systemic sclerosis, a disease often associated with PAH, serotonin induces fibroblast collagen synthesis by TGF-β1–dependent signaling through the 5-hydroxytryptamine2B receptor.(38) 5-Hydroxytryptamine2B is upregulated in the small arteries of patients with idiopathic PAH, and vascular remodeling after hypoxia is…”
Tawfik, M. K., & Makary, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.014 · Cited by 29
Chavan, S. G., Yagati, A. K., Kim, H. T., Jin, E., Park, S. R., Patil, D. V., & Lee, M. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113447 · Cited by 28
The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential
Kim, S., Park, H. J., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416154 · Cited by 28
“Serotonin released by platelets induced ECM synthesis in fibroblasts via activation of the TGF-β signaling pathway [65].”
BackgroundActivation of pregnane X receptor inhibits experimental dermal fibrosis
Beyer, C., Skapenko, A., Distler, A., Dees, C., Reichert, H., Munoz, L. E., Leipe, J., Schulze‐Koops, H., Distler, O., Schett, G. A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202476 · Cited by 28
Self-citationPathological Insight into 5-HT2B Receptor Activation in Fibrosing Interstitial Lung Diseases
Löfdahl, A., Tornling, G., Wigén, J., Larsson‐Callerfelt, A., Wenglén, C., & Westergren‐Thorsson, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010225 · Cited by 29
“In general, dysregulated endothelial permeability and vascular leakage are common features in ILDs [38,76].”
BackgroundMethodResultInfluentialA Platelet-Inspired Paradigm for Nanomedicine Targeted to Multiple Diseases
Modery-Pawlowski, C. L., Kuo, H.-H., rd, W. M. B., & Gupta, A. S. (2013) · Nanomedicine · doi:10.2217/nnm.13.113 · Cited by 27
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting
Romano, E., Rosa, I., Fioretto, B. S., Matucci‐Cerinic, M., & Manetti, M. (2021) · Current Molecular Medicine · doi:10.2174/0929867328666210325102749 · Cited by 26
Increased Platelet Binding to Circulating Monocytes in Idiopathic Pulmonary Fibrosis
Fahim, A., Crooks, M. G., Morice, A. H., & Hart, S. P. (2014) · Lung · doi:10.1007/s00408-013-9546-5 · Cited by 26
“Platelets are attractive candidates for linking vascular dysfunction with tissue fibrosis [8].”
BackgroundTreating skin and lung fibrosis in systemic sclerosis: a future filled with promise?
Antic, M., Distler, J. H. W., & Distler, O. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.016 · Cited by 23
Self-citationChavan, S. G., Yagati, A. K., Koyappayil, A., Go, A., Yeon, S., Lee, T., & Lee, M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02747 · Cited by 22
Mechanisms of fibrotic tissue remodelling: insights from systemic sclerosis
Distler, J. H. W., Launay, D., Feghali‐Bostwick, C. A., Matei, A.-E., Trojanowska, M., & Gudjonsson, J. E. (2026) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01349-z · Cited by 21
Self-citationThe Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis
Guo, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030842 · Cited by 21
Updates on animal models of systemic sclerosis
Soare, A., Ramming, A., Avouac, J., & Distler, J. H. W. (2016) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000220 · Cited by 21
“The molecular pathways activated by mutant fibrillin in Tsk-1 mice resemble those in SSc with activation of central pro-fibrotic pathways (40-43).”
BackgroundSelf-citationSaketkoo, L. A., Magnus, J. H., & Doyle, M. K. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182a55d24 · Cited by 21
“Fibrosis, although the hallmark of SSc, appears to be a late event in a complex web of potentially hundreds of layered, cascading and coincident processes, whereby the deposition of collagen and other components ultimately replace the normal architecture of blood vessels, internal organs and skin.(11,12,15,34,37,44) T…”
BackgroundAntidepressants induce profibrotic responses via the lysophosphatidic acid receptor LPA1
Olianas, M. C., Dedoni, S., & Onali, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172963 · Cited by 20
Kekewska, A., Görnemann, T., Jantschak, F., Glusa, E., & Pertz, H. H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187906 · Cited by 19
“Serotonin 5-HT2A and/or 5-HT2B receptor activation is involved in fibrotic disorders such as valvular heart disease, idiopathic pulmonary fibrosis, skin fibrosis, liver fibrosis, and nephropathies (Grewal et al., 1999; Ruddell et al., 2006; Roth, 2007; Königshoff et al., 2010; Dees et al., 2011; Hutcheson et al., 2011…”
BackgroundChen, C., Ho, Y., Ho, H., Liang, L., Jiang, W., Lee, G.-L., Lee, J., Hsu, Y., Kuo, C.-C., Wu, K. K., et al. (2019) · Aging · doi:10.18632/aging.102350 · Cited by 19
“Plateletderived serotonin (5-hydroxytryptamine) and its receptor signaling links vascular disease and tissue fibrosis [14].”
BackgroundSpecker, E., Matthes, S., Wesołowski, R., Schütz, A., Grohmann, M., Alenina, N. V., Pleimes, D., Mallow, K., Neuenschwander, M., Gogolin, A., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00598 · Cited by 19
Self-citationFrom pathogenesis to therapy – Perspective on treatment strategies in fibrotic diseases
Ramming, A., Dees, C., & Distler, J. H. W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.06.012 · Cited by 19
Self-citationPalmqvist, N., Siller, M., Klint, C., & Sjödin, A. M. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0127-2 · Cited by 18
Sirolimus for kaposiform hemangioendothelioma: Potential mechanisms of action and resistance
Qiu, T., Xiang, S., Zhou, J., Yang, M. J., Lan, Y., Zhang, X., Gong, X., Zhang, Z., & Ji, Y. (2024) · International Journal of Cancer · doi:10.1002/ijc.35207 · Cited by 17
“Through an elaborate study, Dees et al. 124 reported that platelet activation is associated with the development of fibrosis, whereas the inhibition of platelet activation can inhibit fibrotic processes in different models of skin fibrosis.”
Chen, L., Chen, G., Guo, Y.-B., Liu, L., Li, X., Fan, W., Shi, B., & Qian, Y. (2014) · Liver Transplantation · doi:10.1002/lt.23947 · Cited by 17
Molecular targets for therapy in systemic sclerosis
Iwamoto, N., & Distler, O. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s19 · Cited by 17
“Based on these considerations and the fact that 5-HT is elevated in the blood of SSc patients [13-15], we hypothesized that 5-HT signaling might be involved in the process of fibrosis in SSc [11].”
BackgroundSelf-citationLöfdahl, A., Rydell‐Törmänen, K., Larsson‐Callerfelt, A., Wenglén, C., & Westergren‐Thorsson, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-20430-0 · Cited by 17
Ntelis, K., Gkizas, V., Filippopoulou, A., Davlouros, P. A., Alexopoulos, D. K., Andonopoulos, A. P., & Daoussis, D. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1072-1 · Cited by 16
The roles of serotonin in cell adhesion and migration, and cytoskeletal remodeling
Jayakumar, J. A. K. J., & Panicker, M. M. (2021) · Cell Adhesion & Migration · doi:10.1080/19336918.2021.1963574 · Cited by 15
“and inhibitors of serotonin receptors such as 5-HT2A and 5-HT2B play protective roles [55,56].”
BackgroundSerotonin and systemic sclerosis. An emerging player in pathogenesis
Sagonas, I., & Daoussis, D. (2021) · Joint Bone Spine · doi:10.1016/j.jbspin.2021.105309 · Cited by 15
Jordan, S., Chung, J. B., & Distler, O. (2013) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000434598.51526.0e · Cited by 15
“If additional targeting of canonical TGF-b pathways is considered, it should first be analyzed in vitro to ascertain whether this has additive effects on ECM synthesis [7].”
BackgroundSelf-citationIs There Evidence for Vasculitis in Systemic Sclerosis?
Saketkoo, L. A., & Distler, O. (2012) · Current Rheumatology Reports · doi:10.1007/s11926-012-0296-9 · Cited by 15
Self-citationSerotonin—A Driver of Progressive Heart Valve Disease
Waldum, H. L., & Wahba, A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.774573 · Cited by 14
Kim, E., Kim, H. K., Sul, J. H., Lee, J., Baek, S. H., Cho, Y., Han, J., Kim, J., Park, S., Park, J. H., et al. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.191 · Cited by 14
“Histological sections (5 μ m) were cut from paraffin blocks and stained with H&E and Masson’s trichrome, according to a common protocol (Dees et al ., 2011).”
Lin, S., Wang, L., Han, C., Dai, Y., Li, C., Liu, Y., Zhang, B., Huang, N., Zhang, A., Zhang, T., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae130 · Cited by 13
FIBROSIS AND ATRIAL FIBRILLATION — МECHANISMS AND TREATMENT
Drapkina, O. M., & Emelyanov, I. M. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-6-487-494 · Cited by 13
Elaidy, S. M., & Essawy, S. S. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.08.005 · Cited by 13
Therapeutic molecular targets of SSc-ILD
Zhang, Y., & Distler, J. H. W. (2020) · Journal of Scleroderma and Related Disorders · doi:10.1177/2397198319899013 · Cited by 13
Self-citationRole of Alarmins in the Pathogenesis of Systemic Sclerosis
Giovannetti, A., Straface, E., Rosato, E., Casciaro, M., Pioggia, G., & Gangemi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144985 · Cited by 13
Serotonin augments smooth muscle differentiation of bone marrow stromal cells
Hirota, N., McCuaig, S., O’Sullivan, M. J., & Martin, J. G. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.02.003 · Cited by 13
Emerging targeted therapies in scleroderma lung and skin fibrosis
Maurer, B., & Distler, O. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.11.007 · Cited by 12
Self-citationMechanisms of Vascular Disease
Manetti, M., & Kahaleh, B. (2016) · Springer eBooks · doi:10.1007/978-3-319-31407-5_16 · Cited by 12
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice
Fefeu, M., Blatzer, M., Kneppers, A. E. M., Briand, D., Rocheteau, P., Haroche, A., Hardy, D., Juchet-Martin, M., Danckaert, A., Coudoré, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50220-4 · Cited by 11
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
Štorkánová, H., Štorkánová, L., Navrátilová, A., Bečvář, V., Hulejová, H., Oreská, S., Heřmánková, B., Špiritović, M., Bečvář, R., Pavelká, K., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9060650 · Cited by 11
“, formation of tumors, hemorrhages, presence of pus, or other significant pathologies [27,28,36,37].”
BackgroundMethodSelf-citationSibutramine, a serotonin–norepinephrine reuptake inhibitor, causes fibrosis in rats
Oberholzer, H. M., van der Schoor, C., & Bester, M. J. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.05.011 · Cited by 11
Invited Commentary: The Hunt for Mechanistic Origins of Liver Fibrosis in the Fontan Circulation
Rychik, J. R., & Goldmuntz, E. (2021) · World Journal for Pediatric and Congenital Heart Surgery · doi:10.1177/2150135121989974 · Cited by 11
“Vascular damage and dysfunction with release of serotonin from the dense granules of activated platelets strongly induces extracellular matrix production via activation of serotonin receptors in a TGFb1-dependent manner.(19) Vascular dysfunction present in a Fontan circulation makes the serotonin system a strong candi…”
BackgroundMouthon, L. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.203 · Cited by 10
Platelets: “First Responders” in Cancer Progression and Metastasis
Menter, D. G., Davis, J. S., Tucker, S. C., Hawk, E. T., Crissman, J. D., Sood, A. K., Kopetz, S., & Honn, K. V. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_74 · Cited by 10
de Abreu, A. V., Rondina, M. T., Weyrich, A. S., & Zimmerman, G. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00036-5 · Cited by 10
Central Retinal Vein Occlusion in 2 Patients Using Antipsychotic Drugs
Taki, K., Kida, T., Fukumoto, M., Sato, T., Oku, H., & Ikeda, T. (2017) · Case Reports in Ophthalmology · doi:10.1159/000479219 · Cited by 10
Kaufman, J., Nabozny, G. H., Manh, C. T., Liebel, C., Zhou, X., Daley, L.-A., Wang, C.-T., Ebenezer, D. L., Delić, D., Wohnhaas, C. T., et al. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf109 · Cited by 9
Self-citationTryptophan metabolism is dysregulated in individuals with Fanconi anemia
Bartlett, A. L., Romick‐Rosendale, L. E., Nelson, A., Abdullah, S., Luebbering, N., Bartlett, J. R., Brusadelli, M. G., Palumbo, J. S., Lake, K. E., Litts, B., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002794 · Cited by 9
“Platelets store and transport serotonin produced by enterochromaffin cells in the gut in dense granules, and TGF-b is similarly transported in a granules.(34,35,39,40,51,52) We therefore expected that serotonin and TGF-b levels would be correlated with platelet count, and indeed found this to be true in transplant rec…”
BackgroundCentral retinal vein occlusion in a patient using the antipsychotic drug olanzapine: a case report
Nowrouzi, A., Kafi-abasabadi, S., Rodríguez-Calzadilla, M., Sánchez, J. B. D. C., Soto-Guerrero, A., Diaz-Ramos, A., & Marques-Cavalcante, K. V. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-02865-8 · Cited by 9
“5-HT2A blockers stimulate 5-HT2A in the platelets and induce platelet aggregation, causing the vascular smooth muscles to contract [22, 23].”
BackgroundReduction in and Preventive Effects for Oral-Cancer Risk with Antidepressant Treatment
Chung, C., Kuo, T., Yeh, K., Lee, C., & Ko, Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070591 · Cited by 9
“Serotonin and the 5-HT2B receptor are associated with fibrosis [50].”
BackgroundSystemic Sclerosis - An Update on the Aberrant Immune System and Clinical Features
Radstake, T. R. D. J. (2012) · InTech eBooks · doi:10.5772/1326 · Cited by 8
Development of Pharmacophore Models for the Important Off-Target 5-HT2B Receptor
Schieferdecker, S., & Vock, E. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01679 · Cited by 8
Pulmonary 5-HT2B receptor expression in fibrotic interstitial lung diseases
Löfdahl, A., Nybom, A., Wigén, J., Dellgren, G., Brunnström, H., Wenglén, C., & Westergren‐Thorsson, G. (2023) · Acta Histochemica · doi:10.1016/j.acthis.2023.152024 · Cited by 8
The Pathogenesis of Scleroderma
Gupta, L., Ahmed, S., & Zanwar, A. A. (2017) · Indian Journal of Rheumatology · doi:10.4103/0973-3698.219083 · Cited by 8
“[22] The lung is an important organ in catabolism of serotonin; increased serotonin due to platelet activation may be a possible explanation for lung fibrosis in SSc. Bleomycin mice fail to develop fibrosis when serotonin 5 HT2c receptors are knocked out.”
The Role of Platelets in Inflammation
Rondina, M. T., & Zimmerman, G. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00028-x · Cited by 8
Gene Structure, Expression, and 5-HT2B Receptor Signaling
Maroteaux, L. (2021) · The Receptors · doi:10.1007/978-3-030-55920-5_1 · Cited by 8
Self-citationPetrić, M., Perković, D., Božić, I., Krstulović, D. M., & Kaliterna, D. M. (2022) · Medicina · doi:10.3390/medicina58020161 · Cited by 8
“showed that cultured dermal fibroblasts from SSc patients and healthy individuals respond to serotonin by increased extracellular matrix synthesis [17].”
BackgroundInfluentialPlatelet-rich plasma: the role in neural repair
Giorgetti, M., & Siciliano, G. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.172310 · Cited by 8
“Fibroblasts are drawn into the fibrin clot by PDGF and TGF β .”
InfluentialSerotonin, immune function, and psychedelics as potent anti-inflammatories
Nichols, C. D., & Foster, T. P. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.04.011 · Cited by 7
Fibrogenesis, novel lessons from animal models
Langhe, E. D., & Lories, R. J. U. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0510-8 · Cited by 7
“, the serotonin pathway [76], the cannabinoid system [77], and endothelin-”
BackgroundKendall, R. T., Renaud, L., Baatz, J. E., Malaab, M., Nguyen, X.-X., & Feghali‐Bostwick, C. A. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104243 · Cited by 7
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases
Péč, M. J., Jurica, J., Péčová, M., Benko, J., Sokol, J., Bolek, T., Samec, M., Hurtová, T., Galajda, P., Samoš, M., et al. (2023) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0043-1777071 · Cited by 7
“60 Inhibition of platelet activation or serotonin synthesis by its inhibitor terguride in mouse models has alleviated fi brosis.”
Background
Metadata
- Authors
- Dees, C., Akhmetshina, A., Zerr, P., Reich, N., Palumbo, K., Horn, A., Jüngel, A., Beyer, C., Krönke, G., Zwerina, J., Reiter, R., Alenina, N., Maroteaux, L., Gay, S., Schett, G., Distler, O., & Distler, J. H. W.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University Hospital Zurich (CH)
- ErgoNex Pharma GmbH, CH-9050 Appenzell, Switzerland 3
- Max Delbrück Center (DE)
- Inserm (FR)
- Corresponding author
- Distler, Jörg H.W.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2011-04-25
- Volume
- 208
- Issue
- 5
- Pages
- 961-972
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3092343
- OpenAlex
- W2025287936
- Cited by
- 266
- References
- 63
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 22 · 2020: 22 · 2019: 14 · 2018: 22 · 2017: 12 · 2016: 20 · 2015: 16 · 2014: 21 · 2013: 21 · 2012: 37
- FWCI
- 19.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- serotonin, platelets, 5-HT2B receptor, skin fibrosis, systemic sclerosis, extracellular matrix synthesis, fibroblasts, TGF-beta signaling, platelet activation, vascular injury, tissue remodeling, tryptophan hydroxylase 1, therapeutic target
- MeSH terms
- Animals, Blood Platelets, Disease Models, Animal, Extracellular Matrix, Fibroblasts, Fibrosis, Humans, Scleroderma, Systemic, Serotonin, Signal Transduction, Platelet Activation, Transforming Growth Factor beta, Mice, Knockout, Receptor, Serotonin, 5-HT2B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.